Chemical Industry News, Data & Insights

Verona Pharma plc

About Verona Pharma

Verona Pharma plc is a biopharmaceutical company focused on developing therapies for chronic respiratory diseases. The company concentrates on conditions with high unmet medical need, such as chronic obstructive pulmonary disease (COPD) and non-cystic fibrosis bronchiectasis, aiming to improve symptom control and reduce exacerbations.

Its lead program is ensifentrine, an inhaled, first-in-class dual phosphodiesterase 3 and 4 (PDE3/PDE4) inhibitor designed to provide both bronchodilator and non-steroidal anti-inflammatory effects in a single molecule. Verona Pharma advances its candidates through clinical development and works with healthcare stakeholders to enable access to new treatments for respiratory patients.

Get insights on Verona Pharma
with chemXplore Analytics